{
    "organizations": [],
    "uuid": "473f9e647a27aa3928f2d553a31dffdf0811f487",
    "author": "",
    "url": "https://www.reuters.com/article/brief-concert-pharma-says-fda-granted-fa/brief-concert-pharma-says-fda-granted-fast-track-designation-to-ctp-543-idUSASB0C0T3",
    "ord_in_thread": 0,
    "title": "BRIEF-Concert Pharma Says FDA Granted Fast Track Designation To CTP-543",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": " 14 PM / Updated 7 minutes ago BRIEF-Concert Pharma Says FDA Granted Fast Track Designation To CTP-543 Reuters Staff \nJan 12 (Reuters) - Concert Pharmaceuticals Inc: \n* FDA GRANTS FAST TRACK DESIGNATION TO CONCERT PHARMACEUTICALS’ CTP-543 FOR THE TREATMENT OF ALOPECIA AREATA \n* CONCERT PHARMA SAYS U.S. FDA GRANTED FAST TRACK DESIGNATION FOR CO‘S CTP-543 Source text for Eikon: Further company coverage:",
    "published": "2018-01-12T14:13:00.000+02:00",
    "crawled": "2018-01-12T14:28:14.023+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "pm",
        "updated",
        "minute",
        "ago",
        "pharma",
        "say",
        "fda",
        "granted",
        "fast",
        "track",
        "designation",
        "reuters",
        "staff",
        "jan",
        "reuters",
        "concert",
        "pharmaceutical",
        "inc",
        "fda",
        "grant",
        "fast",
        "track",
        "designation",
        "concert",
        "pharmaceutical",
        "treatment",
        "alopecia",
        "areata",
        "concert",
        "pharma",
        "say",
        "fda",
        "granted",
        "fast",
        "track",
        "designation",
        "co",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}